Shivraj Singh Chouhan hails scientists behind India's first indigenous bird flu vaccine
Synopsis
Key Takeaways
Months of sleepless nights, zero holidays, and round-the-clock research — that is what Union Agriculture Minister Shivraj Singh Chouhan says stands behind India's first indigenously developed bird flu vaccine, a milestone he celebrated on Friday, November 20, 2026.
Chouhan posted a tribute in Hindi, writing: 'Bharat ki pehli swadeshi bird flu vaccine ke peeche hamare vaigyanikon ki kai mahino ki mehnat, sadhana aur tapasya hai' — 'Behind India's first indigenous bird flu vaccine lies the months of hard work, dedication, and penance of our scientists.' He added that the researchers had shown the devotion of a soldier, working day and night without taking a single leave, under the hashtag #SwadeshiVaccine.
Why a homegrown avian flu vaccine matters for Indian poultry
Avian influenza — bird flu — has triggered periodic, economically devastating outbreaks across Indian poultry belts, from Maharashtra and Kerala to Himachal Pradesh and West Bengal. Each outbreak forces mass cullings and hammers livelihoods for millions of small-scale poultry farmers who operate on razor-thin margins. Until now, India's response has largely depended on imported diagnostic tools and control measures, with no domestic vaccine in the arsenal.
An indigenous vaccine changes that equation. It could cut procurement costs, enable faster stockpiling, and give India sovereign control over supply in a crisis — the same logic that drove the Atmanirbhar Bharat framework into the human health space, most visibly with Covaxin in 2021. The same philosophy is now extending to animal health.
ICAR's role and the road to farmers' fields
Institutes under the Indian Council of Agricultural Research (ICAR) have long worked on avian disease management, and domestic scientific capacity in this area has been a stated priority for the Agriculture Ministry. Chouhan's tribute to scientists working without breaks signals that this vaccine is the product of an intensive, sustained push — not a routine laboratory exercise.
The critical next steps are regulatory clearances, robust field trials across geographically diverse poultry zones, and a commercial rollout plan that can actually reach smallholder farmers in affected states. How quickly those hurdles are cleared will determine whether this achievement translates from a laboratory milestone into real protection on the ground.
India's poultry sector — worth hundreds of billions of rupees and employing millions — deserves nothing less than a fast follow-through.